Skip to main content

Table 4 Effect of IPTp-SP doses on maternal anaemia, fetal anaemia and preterm delivery

From: Effect of sulfadoxine-pyrimethamine doses for prevention of malaria during pregnancy in hypoendemic area in Tanzania

Outcome

Univariate analysis

Multivariable analysis

 

n (%)

cOR, 95% CI

p-value

aOR, 95% CI

p-value

Maternal anemia

 0–2 doses

187 (47.1)

1.23 (0.96–1.57)

0.10

1.36 (1.04–1.79)

0.02a

 ≥ 3 doses

321 (42.0)

Ref

Ref

Ref

Ref

Fetal anemia

 0–2 doses

36 (9.1)

0.84 (0.56–1.27)

0.41

0.85 (0.54–1.34)

0.49b

 ≥ 3 doses

81 (10.6)

Ref

Ref

Ref

Ref

Preterm delivery

 0–2 doses

37 (9.3)

1.38 (0.89–2.14)

0.15

1.06 (0.65–1.73)

0.81c

 ≥ 3 doses

53 (6.9)

Ref

Ref

Ref

Ref

  1. a Adjusted for placental malaria, ANC visits, FEFO use, peripheral malaria, mebendazole, ITN, mosquito spray/repellent and gravidity
  2. b Adjusted for placental malaria, ANC visits, FEFO use, peripheral malaria, mebendazole, ITN, mosquito spray/repellent, maternal anaemia, sex of newborn and gravidity
  3. c Adjusted for placental malaria, ANC visits, FEFO use, peripheral malaria, mebendazole, ITN, mosquito spray/repellent, gravidity, maternal anaemia and age of mothers